Skip to main content
logo
GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
48.74
-2.20 (-4.32%)
At close: Oct 28, 2026, 4:00 PM EDT
48.81
+0.07 (0.14%)
After-hours: Oct 28, 2026, 7:54 PM EDT

GSK Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
-8,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,1477,1786,9517,3767,8296,9297,1907,076
Revenue Growth (YoY)
-5.30%1.50%6.17%6.68%1.29%2.08%0.81%-1.66%9.84%5.93%9.16%4.06%3.59%-3.32%4.24%18.14%18.69%39.48%-19.03%
Cost of Revenue
-2,0721,8732,6172,2392,1651,9262,5372,3282,0621,9182,3372,2431,8991,9032,6872,2142,1452,6902,761
Gross Profit
-6,3375,7566,0016,3085,8215,5905,5805,6845,8225,4455,7155,9045,2795,0484,6895,6154,7844,5004,315
Selling, General & Admin
-2,1922,0852,6662,1622,1312,0542,6213,7672,3892,0702,5952,2122,2572,0652,4222,0141,9591,7842,046
Research & Development
-1,7471,5182,1381,5751,5441,3971,8361,4411,4281,3731,7991,4481,3351,2401,5571,3141,1811,1111,309
Other Operating Expenses
--204-615-434-511-246-171120-191-144-303-400-521-315-180-185-255-65-214-102
Operating Expenses
-3,7352,9884,3703,2263,4293,2804,5775,0173,6733,1403,9943,1393,2773,1253,7943,0733,0752,6813,253
Operating Income
-2,6022,7681,6313,0822,3922,3101,0036672,1492,3051,7212,7652,0021,9238952,5421,7091,8191,062
Interest Expense
--182-167-145-167-184-162-120-155-174-166-146-180-184-199-213-199-203-205-183
Interest & Investment Income
-58221726505444322432222433291222217-
Earnings From Equity Investments
--3-4-14-2---1-1-1-1--2-22-1-2-1-2
Other Non Operating Income (Expenses)
----21----63----74----46----6
EBT Excluding Unusual Items
-2,4752,6191,4812,9452,2562,2028645431,9982,1701,5222,6091,8491,7516502,3641,5251,620871
Merger & Restructuring Charges
--23-24-18-58-13-20-72-101-124-57-118-110-47-108-62-73-135-51-158
Gain (Loss) on Sale of Investments
----24---57----122--1256---37
Gain (Loss) on Sale of Assets
---106---246---61---215---552
Asset Writedown
--1,895-172-236-112-476-64-202-17-47-54-269-129-4-16280-198-5516-64
Legal Settlements
---------------922----
Other Unusual Items
--203-279-359-319120-10-330-361-332-704-695-579189279-635-1,081-439509-935
Pretax Income
-3542,1449502,4561,8872,108563641,4951,3553791,7911,9871,9071,6261,0128962,094303
Income Tax Expense
--19930522331224133662-1191274-192572422761233150323-117
Earnings From Continuing Operations
-5531,8397272,1441,6461,772501651,3041,0813981,5341,7451,6311,6257797461,771420
Earnings From Discontinued Operations
----------------510,062132306323
Net Income to Company
-5531,8397272,1441,6461,772501651,3041,0813981,5341,7451,6311,62010,8418782,077743
Minority Interest in Earnings
--118-102-91-131-203-148-87-123-131-35-48-70-121-141-125-20-40-2756
Net Income
-4351,7376362,0131,4431,624414-581,1731,0463501,4641,6241,4901,49510,8218381,802749
Net Income to Common
-4351,7376362,0131,4431,624414-581,1731,0463501,4641,6241,4901,49510,8218381,802749
Net Income Growth (YoY)
--69.85%6.96%53.62%-23.02%55.26%18.29%--27.77%-29.80%-76.59%-86.47%93.80%-17.31%99.60%826.45%-39.93%67.94%10.63%
Shares Outstanding (Basic)
4,0094,0144,0234,0194,0344,0634,0884,0814,0804,0794,0694,0564,0554,0534,0444,0344,0304,0254,0164,009
Shares Outstanding (Diluted)
4,0734,0624,0744,0864,1024,1104,1374,1454,1414,1224,1134,1164,1124,0934,0854,0914,0884,0644,0664,061
Shares Change (YoY)
-0.71%-1.17%-1.52%-1.42%-0.94%-0.29%0.58%0.70%0.70%0.71%0.69%0.61%0.59%0.71%0.47%0.74%0.84%0.64%0.89%0.68%
EPS (Basic)
0.380.110.430.160.500.360.400.10-0.010.290.260.090.360.400.370.372.690.210.450.19
EPS (Diluted)
0.380.110.430.160.490.350.390.10-0.010.280.250.090.360.400.360.372.650.210.440.18
EPS Growth (YoY)
-22.81%-69.52%8.40%54.72%-23.16%54.72%17.32%--28.21%-30.41%-76.55%-86.55%92.27%-17.84%98.82%819.92%-40.29%67.08%9.19%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
2,4352,3629201,7051,9111,8409371,7851,8498117102,7101,9131,011-1801,4671,0461,3982,3493,393
Free Cash Flow Per Share
0.600.580.230.420.470.450.230.430.450.200.170.660.470.25-0.040.360.260.340.580.84
Dividend Per Share
0.1700.1700.1700.1800.1600.1600.1600.1600.1500.1500.1500.1600.1400.1400.1400.1380.1380.1630.1750.287
Dividend Growth (YoY)
6.25%6.25%6.25%12.50%6.67%6.67%6.67%0%7.14%7.14%7.14%16.36%1.82%-13.85%-20.00%-52.17%-42.10%-31.58%-26.32%0%
Gross Margin
74.91%75.36%75.45%69.63%73.80%72.89%74.38%68.75%70.94%73.85%73.95%70.98%72.47%73.54%72.62%63.57%71.72%69.04%62.59%60.98%
Operating Margin
-30.94%36.28%18.93%36.06%29.95%30.73%12.36%8.33%27.26%31.30%21.37%33.94%27.89%27.66%12.13%32.47%24.66%25.30%15.01%
Profit Margin
-5.17%22.77%7.38%23.55%18.07%21.61%5.10%-0.72%14.88%14.21%4.35%17.97%22.63%21.44%20.27%138.22%12.09%25.06%10.59%
Free Cash Flow Margin
-28.09%12.06%19.78%22.36%23.04%12.47%21.99%23.08%10.29%9.64%33.66%23.48%14.09%-2.59%19.89%13.36%20.18%32.67%47.95%
EBITDA
-2,8253,2312,6893,8203,0113,1331,8491,6182,7882,8541,9513,3442,4542,5631,3373,4982,6262,2371,369
EBITDA Margin
64.11%33.60%42.35%31.20%44.69%37.70%41.68%22.78%20.20%35.36%38.76%24.23%41.05%34.19%36.87%18.12%44.68%37.90%31.11%19.35%
D&A For EBITDA
2,8412234631,058738619823846951639549230579452640441.75956917418307
EBIT
-2,6022,7681,6313,0822,3922,3101,0036672,1492,3051,7212,7652,0021,9238952,5421,7091,8191,062
EBIT Margin
32.14%30.94%36.28%18.93%36.06%29.95%30.73%12.36%8.33%27.26%31.30%21.37%33.94%27.89%27.66%12.13%32.47%24.66%25.30%15.01%
Effective Tax Rate
11.99%-14.23%23.47%12.70%12.77%15.94%11.01%-12.78%20.22%-14.35%12.18%14.47%0.06%23.02%16.74%15.43%-
SEC Filings: 10-K · 10-Q